He doesn't really talk to us, all he said was 'T-cells are only part of the issue, we need a B-cell test as well, tovaxin is only half the answer'.
To be honest he asked us 'have you decided to start any interferon treatment' and she'd already been on Rebif for nearly six months.
Doesn't really inspire confidence.
I'm not saying that I would trust your doctor either (make sure to remind him to test her liver function with blood tests regularly while she is taking Rebif)
But about tovaxin, it could be that Tovaxin never becomes an approved medication to treat ms. Or, it could simply be less effective than some had hoped for. We will have a better idea of what to expect once the results of the phase IIb study are published. Being in this clinical trial, I simply cannot wait for the company to publish results from the study. The one year data should be published in October but I would be happy to see interim results published.